Titled “Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution”, the thematic panel session co-organised by Gleneagles Hong Kong and Hong Kong Trade Development Council (HKTDC) was moderated by Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia.
With the pervasive adoption of AI driving a paradigm shift across industries, including healthcare, the session explored how artificial intelligence could deliver measurable clinical and operational impact at scale.
Bringing together leaders from healthcare, academia, innovators and the technology sector, the panelists
- Professor Joshua Ho, Assistant Dean (Innovation & Technology Transfer) at the Li Ka Shing Faculty of Medicine, The University of Hong Kong;
- Professor Kwang Joon Kim, Co-founder and Chief Executive Officer at AITRICS;
- Professor Aurel Kun Qian, Co-founder & Chief Medical Officer at SenseCare (healthcare arm of SenseTime); and
- Mr Kwok Quek Sin, Group Chief Business Technology Officer at IHH Healthcare,
discussed key priorities shaping AI adoption in healthcare, including scaling solutions from pilot to practice, strengthening cross‑sector collaboration, and ensuring robust clinical validation, governance and trust in the use of AI. The discussion also examined real-life examples of challenges and opportunities in scaling the use of AI in clinical settings and highlighted that trust is among one of the fundamentals to the successful adoption of AI in healthcare.
Dr Tsang emphasised that AI is not about replacing people, but about empowering healthcare professionals through upskilling and engagement to work confidently alongside technology. By building practical, scalable and trusted AI solutions in close partnership with stakeholders including doctors, AI enables new models of care and deliver meaningful, sustainable impact for patients and clinicians alike.
The Asia Summit on Global Health (ASGH) jointly organised by the Government of the Hong Kong Special Administrative Region and the HKTDC was held on 11 – 12 May. Themed “Fuelling Healthcare Breakthroughs”, the event enabled Gleneagles Hong Kong to showcase and share its commitment to strengthening cross‑sector collaboration to foster the adoption of transformative and data‑enabled care models, supporting clinical excellence and improved patient outcomes.
Related Stories
.jpg?sfvrsn=745604e1_1)
Gleneagles Hong Kong Leads the Way in Advancing Liver Cancer Care
Gleneagles Hong Kong and HKUMed are advancing liver cancer care through collaboration and innovation under IHH Healthcare’s leadership.
55fda2dc551e4ff68748a1aabe8694a6.jpg?sfvrsn=a1e3ed8c_1)
Parkway East Hospital Supports Healthy Ageing with Its New Live Well Centre and Sleep Laboratory
Future of Work: AI Agents in Action Hackathon Highlights AI Solutions for Healthcare and Business Challenges
The Future of Work: AI Agents in Action Hackathon invited colleagues from across the IHH network to explore how AI agents can help solve everyday challenges in healthcare and business operations.
Gleneagles Hong Kong Champions Health and Wellness at Hong Kong Cyclothon
IHH Healthcare's Gleneagles Hospital Hong Kong supported the 2026 Hong Kong Cyclothon as the event's Official Wellness Partner, helping promote active living and community wellbeing while providing medical support for one of the city's largest mass participation sporting events.
Pantai Hospital Kuala Lumpur Completes First Iberis® RDN Transradial Procedure Across Pantai Hospitals Group
Pantai Hospital Kuala Lumpur has achieved a cardiovascular care milestone with the successful completion of the first Iberis® renal denervation (RDN) transradial procedure within the Pantai hospital network.
Fortis Expands Advanced Respiratory Care with Dedicated Lung Failure Clinics
Fortis Healthcare, part of IHH Healthcare, is strengthening respiratory and transplant care in Delhi through new multidisciplinary Lung Failure Clinics.
